Ultrahuman launches M2 Live in the United States, a metabolic health platform that provides continuous glucose monitoring and related AI-driven insights. Multiple outlets report that the system is built around Abbott’s Lingo glucose biosensor, which is sold over the counter and does not require a prescription. The sensor streams glucose data to a user’s smartphone via Bluetooth Low Energy, and outlets also note NFC is needed to activate the sensor. Ultrahuman’s software layer adds real-time glucose tracking along with features aimed at interpreting metabolic patterns, including a clinically validated “Metabolic Score” and AI-powered guidance. NDTV adds that the platform includes glucose spike alerts, “Food Score” and “Fueling Score” tools, access to OGDb, and integrations with Ultrahuman Ring and Blood Vision data. One report also notes that M2 Live can work with Abbott’s Libre 3 Plus sensor. Pricing is reported as $129 for a single sensor, with a subscription fee of $99 per month. Overall, the product positions continuous glucose monitoring with lower-cost entry for consumer use.